Archive Newsletter

41. 04.22.21 -- The Case For Confidence In Mesenchymal Stem Cells (MSCs) 4/22/2021
    04/22/21 Cell & Gene Newsletter
42. 04.21.21 -- Mapping 7 Emerging Pharma Development Risks 4/21/2021

    04/21/21 Cell & Gene Newsletter

43. 04.20.21 -- Make Buffer Management And Chromatography Your Competitive Advantages 4/20/2021

    04/20/21 Cell & Gene Newsletter

44. 04.20.21 -- Commercializing HSC Gene Therapies For Rare Disease 4/20/2021
    04/20/21 Cell & Gene Newsletter
45. 04.16.21 -- How To Commercially Scale T-Cell Allogeneic Therapies 4/16/2021

    04/16/21 Cell & Gene Newsletter

46. 04.15.21 -- Rethinking Data Quality Best Practices In The Era Of Decentralized Clinical Trials 4/15/2021

    04/15/21 Cell & Gene Newsletter

47. 04.15.21 -- How ASGCT Is Combatting Skepticism In Science 4/15/2021
    04/15/21 Cell & Gene Newsletter
48. 04.14.21 -- Cell & Gene Therapy Process Development Resources 4/14/2021

    04/14/21 Cell & Gene Newsletter

49. 04.13.21 -- Philly-Based CDMO's Newest Leaders Talk Manufacturing, Commercialization 4/13/2021
    04/13/21 Cell & Gene Newsletter
50. 04.08.21 -- The Rise In Need For In-House Production Facilities 4/8/2021
    04/08/21 Cell & Gene Newsletter